Search Results

You searched for : lupin  

IPA to host the 11th Global Pharmaceutical Quality Summit February 23-24, 2026, Mumbai

JP Nadda, Hon’ble Union Minister for Health & Family Welfare and Minister of Chemicals and Fertilizers to deliver the keynote address at the inaugural session....
Feb 17

IPA’s 10th Advanced GMP Workshop Calls for Unified Quality Vision to Power India’s USD 450 Billion Pharma Ambition

Reinforcing its commitment to strengthening global manufacturing and quality benchmarks, the Indian Pharmaceutical Alliance (IPA) convened the 10th Advanced Good Manufacturing Practices (GMP) Workshop. The ...
Nov 24

Can India’s Generics Take the Centre Stage and End Weight-Loss Monopoly

Generic semaglutide could ultimately become not just an alternative, but the new standard driven by precision manufacturing, scaled access, and cost redefined....
Aug 11

Top 4 Startups Driving Credit Risk Innovation in India’s Healthcare and Pharma Sector

India’s healthcare and pharmaceutical landscape is undergoing a digital financial shift....
Jun 24

Indian Innovation vs Western Monopolies: Lupin’s FDA Triumph Tells a Bigger Story

Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ...
Jun 03

Lupin Digital Health Introduces Comprehensive Post-Procedure Home-Based Care Guide in Collaboration with the American College of Cardiology

...
Mar 24

From Dependence to Dominance: Lupin’s Leap in the Diabetes Market

With a focus on affordability, accessibility, and innovation, Lupin is leading the way for better diabetes management and improved quality of life for patients....
Jan 03

9th Edition of the India Health and Wellness Awards 2024 Celebrate Excellence in Healthcare, Innovations in Health and Patient Centric Approach Recognised

The awards ceremony also featured insightful keynote addresses, panel discussions, and networking opportunities, providing attendees with valuable insights and opportunities for collaboration....
Apr 27

FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation Therapy

Lupin Limited's FDA approval for its generic Varenicline tablets marks a significant milestone in the field of smoking cessation therapy....
Mar 18

 Transforming Cardiac Care in India: Lupin Digital Health and American College of Cardiology Join Forces

The collaboration between Lupin Digital Health and the American College of Cardiology paves the way for a remarkable advancement in cardiovascular care in India. By ...
Jul 26

Growth of India’s Pharmaceutical Companies

Imagine the year 1969. In our domestic pharmaceutical market, Indian companies had a share of a mere 5%. Cut to last year where they had ...
Sep 16

Lupin Launches Tavaborole Topical Solution in the United States

The product will be manufactured at Lupin’s facility in Pithampur, India...
Jul 14

Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets

Sevelamer Hydrochloride Tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis....
Jun 17

Lupin receives UK marketing authorization for Luforbec, first branded generic alternative to Fostair for treatment of Asthma & COPD

...
Jun 14

Lupin Launches Posaconazole Delayed-Release Tablets

Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA...
Feb 17

LupinLife Launches Be One, Ayurvedic Energy Supplement

Be One is a natural, non-addictive and steroid-free daily health supplement for men ...
Feb 10

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ...
Jan 07

Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP

Sulfamethoxazole and Trimethoprim Oral Suspension, is indicated for the treatment and prevention of a wide variety of bacterial infections....
Jan 06

Lupin launches Meloxicam Capsules, received approval from USFDA

Meloxicam Capsules indicated for the management of osteoarthritis pain...
Dec 29

Lupin launches Meloxicam Capsules

Meloxicam Capsules is the generic equivalent of Vivlodex Capsules of Zyla Life Sciences US, Inc., and indicated for the management of osteoarthritis (OA) pain....
Dec 28

Lupin receives approval from US FDA for Colesevelam Hydrochloride tablets

Another USFDA approval for Lupin...
Dec 18

Lupin receives approval from USFDA for Penicillamine Tablets USP

Penicillamine Tablets USP, 250 mg, are indicated in the treatment of Wilson’s disease, Cystinuria, and in patients with severe, active rheumatoid arthritis...
Dec 01

Lupin launches Tacrolimus Capsules USP

Tacrolimus Capsules are the generic equivalent of Prograf Capsules of Astellas Pharma US, Inc. and are indicated for the prophylaxis of organ rejection....
Nov 25

Lupin Pharma, announces US FDA has accepted their new drug application for solosec for the treatment of trichomoniasis

If approved for trichomoniasis, Solosec could be the only single-dose oral prescription treatment for both BV and trichomoniasis ...
Nov 16

Lupin’s Alliance Partner Concord Receives U.S. FDA Approval for Tacrolimus Capsules USP

Tacrolimus Capsules USP are indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney or heart transplants...
Nov 12

25 Matching result(s) found!

-Advertisements-



Trending Now

How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026